(Q33396720)

26 July 2017

title

Pathogen-inactivation of platelet components with the INTERCEPT Blood System ™: a cohort study (English)

1 reference

26 July 2017

5

Alois Gratwohl

1 reference

26 July 2017

Laura Infanti

1

1 reference

26 July 2017

Christine Stebler

2

1 reference

26 July 2017

Shabahang Job

3

1 reference

26 July 2017

Morven Ruesch

4

1 reference

26 July 2017

Johannes Irsch

6

1 reference

26 July 2017

Lily Lin

7

1 reference

26 July 2017

Andreas Buser

8

1 reference

26 July 2017

publication date

15 August 2011

1 reference

Transfusion and Apheresis Science

26 July 2017

published in

1 reference

26 July 2017

volume

45

1 reference

26 July 2017

issue

2

1 reference

26 July 2017

page(s)

175-181

1 reference

Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006).

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.07.013

Clinical significance of bacteriologic screening in platelet concentrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.07.013

Canadian experience with detection of bacterial contamination in apheresis platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.07.013

Prevention of transfusion of platelet components contaminated with low levels of bacteria: a comparison of bacteria culture and pathogen inactivation methods.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.07.013

Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.07.013

Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.07.013

Pathogen-reduction methods: advantages and limits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.07.013

Transmission of tick-borne agents of disease by blood transfusion: a review of known and potential risks in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.07.013

Trypanosoma cruzi inactivation in human platelet concentrates and plasma by a psoralen (amotosalen HCl) and long-wavelength UV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.07.013

Photochemical inactivation with amotosalen and long-wavelength ultraviolet light of Plasmodium and Babesia in platelet and plasma components.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.07.013

Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a Chikungunya virus epidemic in Ile de La Réunion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.07.013

Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.07.013

Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.07.013

An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.07.013

A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.07.013

Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.07.013

A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.07.013

The role of the plasma from platelet concentrates in transfusion reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.07.013

A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.07.013

Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.07.013

A multicenter randomized study of the efficacy of transfusions with platelets stored in platelet additive solution II versus plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.07.013

Prevention of transfusion-associated graft-versus-host disease by inactivation of T cells in platelet components

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.07.013

Dose of prophylactic platelet transfusions and prevention of hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.07.013

Factors influencing 20-hour increments after platelet transfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.07.013

Clinical factors influencing posttransfusion platelet increment in patients undergoing hematopoietic progenitor cell transplantation--a prospective analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.07.013

Patient and product factors affecting platelet transfusion results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.07.013

10.1016/J.TRANSCI.2011.07.013

7 January 2021

Identifiers

DOI

1 reference

26 July 2017

1 reference